BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Roughley M, Sultan AA, Clarson L, Muller S, Whittle R, Belcher J, Mallen CD, Roddy E. Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res Ther 2018;20:243. [PMID: 30376864 DOI: 10.1186/s13075-018-1746-1] [Cited by in Crossref: 18] [Cited by in F6Publishing: 13] [Article Influence: 4.5] [Reference Citation Analysis]
Number Citing Articles
1 Zhang H, Li H, Green AP, Wang M, Yan F, Li M, He Y, Sun W, Yuan X, Lu J, Sun M, Merriman TR, Li C. Association of low-level environmental exposure to cadmium and lead with gout flare using a cohort study design. Chemosphere 2021;280:130648. [PMID: 33932909 DOI: 10.1016/j.chemosphere.2021.130648] [Reference Citation Analysis]
2 Singh JA, Gaffo A. Gout epidemiology and comorbidities. Seminars in Arthritis and Rheumatism 2020;50:S11-6. [DOI: 10.1016/j.semarthrit.2020.04.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
3 Diez-Lopez C, Perez-Contreras J, Andres M. Urate levels and clearance in renal patients under peritoneal dialysis. Nucleosides Nucleotides Nucleic Acids 2021;40:720-31. [PMID: 34085590 DOI: 10.1080/15257770.2021.1934482] [Reference Citation Analysis]
4 Li JW, Yin D, Wang Z, Brigham MD, LaMoreaux BD, Kent JD, Francis-Sedlak M, Johnson RJ, Hadker N, Francis KM, Sanchez HA, Miyasato G. New-Onset Gout as an Independent Risk Factor for Returning to Dialysis After Kidney Transplantation. Transplant Direct 2020;6:e634. [PMID: 33225059 DOI: 10.1097/TXD.0000000000001081] [Reference Citation Analysis]
5 Benavent D, Peiteado D, Martinez-Huedo MÁ, Hernandez-Hurtado M, Balsa A, de Miguel E. Healthcare-related impact of gout in hospitalized patients in Spain. Sci Rep 2021;11:13287. [PMID: 34168227 DOI: 10.1038/s41598-021-92673-3] [Reference Citation Analysis]
6 Guo K, Liang N, Wu M, Chen L, Chen H. Prevalence and Risk Factors for Peripheral Neuropathy in Chinese Patients With Gout. Front Neurol 2022;13:789631. [DOI: 10.3389/fneur.2022.789631] [Reference Citation Analysis]
7 Xu N, Han X, Zhang Y, Huang X, Zhu W, Shen M, Zhang W, Jialin C, Wei M, Qiu Z, Zeng X. Clinical features of gout in adult patients with type Ia glycogen storage disease: a single-centre retrospective study and a review of literature. Arthritis Res Ther 2022;24:58. [PMID: 35219330 DOI: 10.1186/s13075-021-02706-5] [Reference Citation Analysis]
8 Estiverne C, Mount DB. The Management of Gout in Renal Disease. Semin Nephrol 2020;40:600-13. [PMID: 33678314 DOI: 10.1016/j.semnephrol.2020.12.007] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Lyu S, Ding R, Yang S, Chen W, Rao Y, OuYang H, Liu P, Feng Y. Establishment of a clinical diagnostic model for gouty arthritis based on the serum biochemical profile: A case-control study. Medicine (Baltimore) 2021;100:e25542. [PMID: 33879701 DOI: 10.1097/MD.0000000000025542] [Reference Citation Analysis]
10 Abhishek A. Debates in gout management. Curr Opin Rheumatol 2020;32:134-9. [PMID: 31842034 DOI: 10.1097/BOR.0000000000000689] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
11 Yokose C, Lu N, Xie H, Li L, Zheng Y, McCormick N, Rai SK, Aviña-Zubieta JA, Choi HK. Heart disease and the risk of allopurinol-associated severe cutaneous adverse reactions: a general population-based cohort study. CMAJ 2019;191:E1070-7. [PMID: 31570545 DOI: 10.1503/cmaj.190339] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
12 Tseng CC, Wong MC, Liao WT, Chen CJ, Lee SC, Yen JH, Chang SJ. Genetic Variants in Transcription Factor Binding Sites in Humans: Triggered by Natural Selection and Triggers of Diseases. Int J Mol Sci 2021;22:4187. [PMID: 33919522 DOI: 10.3390/ijms22084187] [Reference Citation Analysis]
13 Chittoor G, Haack K, Balakrishnan P, Bizon C, Laston S, Best LG, MacCluer JW, North KE, Umans JG, Franceschini N, Prasad G, Macias-Kauffer L, Villarreal-Molina T, Bharadwaj D, Canizales-Quinteros S, Navas-Acien A, Cole SA, Voruganti VS. Fine mapping and identification of serum urate loci in American Indians: The Strong Heart Family Study. Sci Rep 2019;9:17899. [PMID: 31784582 DOI: 10.1038/s41598-019-52924-w] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
14 Xiao YZ, Ye ZZ, Liang YT, Chen XP, Wang YH, Xu Q, Wei JC. Association Between Chinese Herbal Medicine Therapy and the Risk of Chronic Kidney Disease in Gout Patients. Front Pharmacol 2021;12:661282. [PMID: 34079460 DOI: 10.3389/fphar.2021.661282] [Reference Citation Analysis]
15 Paulsamy P, Venkatesan K, Alshahrani S, Ahmad F, El-sherbiny M, Manoharan V, Periannan K, Ahmed R, Prabahar K, mamiru teressa D, Abdulhay E. Alternate Warm and Cold Therapy (AWCT) on Uricemia, Sleep, Pain, Functional Ability, and Quality of Life (USPFQoL) in Patients with Gout: A Path Forward. Journal of Healthcare Engineering 2022;2022:1-8. [DOI: 10.1155/2022/5471575] [Reference Citation Analysis]
16 Ferrández-Jiménez M, Calabuig I, Peral-Garrido ML, Gómez-Garberí M, Andrés M. Risk of osteoporotic thoracic vertebral fractures in patients with gout. Reumatol Clin (Engl Ed) 2021:S2173-5743(21)00141-6. [PMID: 34294558 DOI: 10.1016/j.reumae.2021.01.002] [Reference Citation Analysis]
17 Dehlin M, Jacobsson L, Roddy E. Global epidemiology of gout: prevalence, incidence, treatment patterns and risk factors. Nat Rev Rheumatol 2020;16:380-90. [PMID: 32541923 DOI: 10.1038/s41584-020-0441-1] [Cited by in Crossref: 56] [Cited by in F6Publishing: 42] [Article Influence: 28.0] [Reference Citation Analysis]
18 Choi HK, McCormick N, Yokose C. Excess comorbidities in gout: the causal paradigm and pleiotropic approaches to care. Nat Rev Rheumatol 2021. [PMID: 34921301 DOI: 10.1038/s41584-021-00725-9] [Reference Citation Analysis]
19 Li X, Sun W, Lu J, He Y, Chen Y, Ren W, Cui L, Liu Z, Wang C, Wang X, Ma L, Cheng X, Han L, Li H, Zhang H, Yuan X, Ji X, Ji A, Merriman TR, Li C. Effects of fenofibrate therapy on renal function in primary gout patients. Rheumatology (Oxford) 2021;60:5020-7. [PMID: 33704429 DOI: 10.1093/rheumatology/keab231] [Reference Citation Analysis]
20 Li JW, Suh M, Brigham MD, Kent JD, LaMoreaux B, Johnson RJ, Mandell BF, Hadker N, Sanchez H, Francis K, Miyasato G. A Retrospective Cohort Study of the Effect of Gout on Mortality Among Patients with a History of Kidney Transplantation. Ann Transplant 2020;25:e920553. [PMID: 32284525 DOI: 10.12659/AOT.920553] [Reference Citation Analysis]